3-Dimensional Pharmaceuticals Overview
- Year Founded
-
1993
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$130M
3-Dimensional Pharmaceuticals General Information
Contact Information
Corporate Office
- 1020 Stony Hill Road
- Morrisville, PA 19067
- United States
Corporate Office
- 1020 Stony Hill Road
- Morrisville, PA 19067
- United States
3-Dimensional Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 28-Mar-2003 | $130M | Completed | Generating Revenue | ||
| 6. IPO | 04-Aug-2000 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A) | 31-Mar-2000 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A) | 01-Jan-1998 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A3) | 13-Mar-1997 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A2) | 11-Oct-1996 | $5.41M | $12M | Completed | Product Development | |
| 1. Early Stage VC (Series A1) | 25-Sep-1996 | $6.61M | $6.61M | Completed | Product Development |
3-Dimensional Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A5 | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Series A4 | ||||||||
| Series A3 | ||||||||
| Series A2 | 4,333,990 | $0.001000 | 10% | $1.25 | $1.25 | 1x | $1.25 | 10.61% |
| Series A1 | 6,926,461 | $0.001000 | $0.1 | $1 | $1 | 1x | $1 | 16.96% |
3-Dimensional Pharmaceuticals Patents
3-Dimensional Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2004319946-A1 | Hdm2-inhibitor complexes and uses thereof | Inactive | 22-Apr-2004 | ||
| WO-2005114173-A2 | Hdm2-inhibitor complexes and uses thereof | Inactive | 22-Apr-2004 | ||
| WO-2005114173-A3 | Hdm2-inhibitor complexes and uses thereof | Inactive | 22-Apr-2004 | ||
| WO-2005023834-A2 | Peptides and compounds that bind to thrombopoietin receptors | Inactive | 28-Aug-2003 | ||
| WO-2005023834-A3 | Peptides and compounds that bind to thrombopoietin receptors | Inactive | 28-Aug-2003 | C07K14/524 |
3-Dimensional Pharmaceuticals Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Abingworth | Venture Capital | Minority | ||
| Associated Partners | PE/Buyout | Minority | ||
| HealthCare Ventures | Venture Capital | Minority | ||
| Michigan Department of Treasury | Government | Minority | ||
| Philadelphia Ventures | Venture Capital | Minority |
3-Dimensional Pharmaceuticals FAQs
-
When was 3-Dimensional Pharmaceuticals founded?
3-Dimensional Pharmaceuticals was founded in 1993.
-
Where is 3-Dimensional Pharmaceuticals headquartered?
3-Dimensional Pharmaceuticals is headquartered in Morrisville, PA.
-
What industry is 3-Dimensional Pharmaceuticals in?
3-Dimensional Pharmaceuticals’s primary industry is Discovery Tools (Healthcare).
-
Is 3-Dimensional Pharmaceuticals a private or public company?
3-Dimensional Pharmaceuticals is a Private company.
-
What is the current valuation of 3-Dimensional Pharmaceuticals?
The current valuation of 3-Dimensional Pharmaceuticals is .
-
What is 3-Dimensional Pharmaceuticals’s current revenue?
The current revenue for 3-Dimensional Pharmaceuticals is .
-
How much funding has 3-Dimensional Pharmaceuticals raised over time?
3-Dimensional Pharmaceuticals has raised $139M.
-
Who are 3-Dimensional Pharmaceuticals’s investors?
Abingworth, Associated Partners, HealthCare Ventures, Michigan Department of Treasury, and Philadelphia Ventures are 5 of 7 investors who have invested in 3-Dimensional Pharmaceuticals.
-
When was 3-Dimensional Pharmaceuticals acquired?
3-Dimensional Pharmaceuticals was acquired on 28-Mar-2003.
-
Who acquired 3-Dimensional Pharmaceuticals?
3-Dimensional Pharmaceuticals was acquired by Johnson & Johnson.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process